NAVISTAR® THERMOCOOL® Catheter

DEVICE2 trials

Sponsors

Biosense Webster, Inc.

Conditions

ArrhythmiaAtrial FibrillationHeart DiseasesVentricular Tachycardia

Phase 3

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

CompletedNCT00116428

Biosense Webster, Inc.Arrhythmia, Atrial Fibrillation, Heart Diseases

Start: 2004-10-01End: 2011-03-01Updated: 2017-10-24

Phase 4

Catheter Evaluation for Endocardial Ablation in Patients With Ventricular Tachycardia

CompletedNCT00412607

Biosense Webster, Inc.Ventricular Tachycardia

Start: 2007-01-31End: 2012-06-30Updated: 2025-02-04

Related Papers

Long-Term Success of Irrigated Radiofrequency Catheter Ablation of Sustained Ventricular Tachycardia: Post-Approval THERMOCOOL VT Trial.

2016-02-01114 citations

Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs.

2010-10-1299 citations

Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

2010-01-01870 citations